AXSM FY 2019 Earnings — Axsome Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AXSMAxsome Therapeutics, Inc.

$8B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$37,330

Operating Income

-$67M

Net Income

-$68M

EPS (Diluted)

$-2.05

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$46M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$221M

Total Liabilities

$42M

Stockholders' Equity

$179M

Cash & Equivalents

$220M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$37,330	-$48,935	+23.7%
Operating Income	-$67M	-$33M	-104.7%
Net Income	-$68M	-$31M	-120.7%